Report Detail

Pharma & Healthcare Global Glucosylceramidase Market Professional Survey Report 2019

  • RnM3816166
  • |
  • 15 October, 2019
  • |
  • Global
  • |
  • 100 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global Glucosylceramidase market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Glucosylceramidase volume and value at global level, regional level and company level. From a global perspective, this report represents overall Glucosylceramidase market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Glucosylceramidase in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Glucosylceramidase manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Amicus Therapeutics, Inc.
Bioorganic Research and Services S.A.
greenovation Biotech GmbH
JCR Pharmaceuticals Co., Ltd.
Pharming Group N.V.
Protalix BioTherapeutics, Inc.
Shire Plc
The International Biotechnology Center (IBC) Generium

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
AVRRD-02
LTI-291
NCGC-607
Pcgin
Others

Segment by Application
Genetic Disorders
Gaucher Disease
Parkinson's Disease
Others


Table of Contents

    Executive Summary

      1 Industry Overview of Glucosylceramidase

      • 1.1 Definition of Glucosylceramidase
      • 1.2 Glucosylceramidase Segment by Type
        • 1.2.1 Global Glucosylceramidase Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 AVRRD-02
        • 1.2.3 LTI-291
        • 1.2.4 NCGC-607
        • 1.2.5 Pcgin
        • 1.2.6 Others
      • 1.3 Glucosylceramidase Segment by Applications
        • 1.3.1 Global Glucosylceramidase Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Genetic Disorders
        • 1.3.3 Gaucher Disease
        • 1.3.4 Parkinson's Disease
        • 1.3.5 Others
      • 1.4 Global Glucosylceramidase Overall Market
        • 1.4.1 Global Glucosylceramidase Revenue (2014-2025)
        • 1.4.2 Global Glucosylceramidase Production (2014-2025)
        • 1.4.3 North America Glucosylceramidase Status and Prospect (2014-2025)
        • 1.4.4 Europe Glucosylceramidase Status and Prospect (2014-2025)
        • 1.4.5 China Glucosylceramidase Status and Prospect (2014-2025)
        • 1.4.6 Japan Glucosylceramidase Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Glucosylceramidase Status and Prospect (2014-2025)
        • 1.4.8 India Glucosylceramidase Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Glucosylceramidase
      • 2.3 Manufacturing Process Analysis of Glucosylceramidase
      • 2.4 Industry Chain Structure of Glucosylceramidase

      3 Development and Manufacturing Plants Analysis of Glucosylceramidase

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Glucosylceramidase Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Glucosylceramidase
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Glucosylceramidase Production and Capacity Analysis
      • 4.2 Glucosylceramidase Revenue Analysis
      • 4.3 Glucosylceramidase Price Analysis
      • 4.4 Market Concentration Degree

      5 Glucosylceramidase Regional Market Analysis

      • 5.1 Glucosylceramidase Production by Regions
        • 5.1.1 Global Glucosylceramidase Production by Regions
        • 5.1.2 Global Glucosylceramidase Revenue by Regions
      • 5.2 Glucosylceramidase Consumption by Regions
      • 5.3 North America Glucosylceramidase Market Analysis
        • 5.3.1 North America Glucosylceramidase Production
        • 5.3.2 North America Glucosylceramidase Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Glucosylceramidase Import and Export
      • 5.4 Europe Glucosylceramidase Market Analysis
        • 5.4.1 Europe Glucosylceramidase Production
        • 5.4.2 Europe Glucosylceramidase Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Glucosylceramidase Import and Export
      • 5.5 China Glucosylceramidase Market Analysis
        • 5.5.1 China Glucosylceramidase Production
        • 5.5.2 China Glucosylceramidase Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Glucosylceramidase Import and Export
      • 5.6 Japan Glucosylceramidase Market Analysis
        • 5.6.1 Japan Glucosylceramidase Production
        • 5.6.2 Japan Glucosylceramidase Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Glucosylceramidase Import and Export
      • 5.7 Southeast Asia Glucosylceramidase Market Analysis
        • 5.7.1 Southeast Asia Glucosylceramidase Production
        • 5.7.2 Southeast Asia Glucosylceramidase Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Glucosylceramidase Import and Export
      • 5.8 India Glucosylceramidase Market Analysis
        • 5.8.1 India Glucosylceramidase Production
        • 5.8.2 India Glucosylceramidase Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Glucosylceramidase Import and Export

      6 Glucosylceramidase Segment Market Analysis (by Type)

      • 6.1 Global Glucosylceramidase Production by Type
      • 6.2 Global Glucosylceramidase Revenue by Type
      • 6.3 Glucosylceramidase Price by Type

      7 Glucosylceramidase Segment Market Analysis (by Application)

      • 7.1 Global Glucosylceramidase Consumption by Application
      • 7.2 Global Glucosylceramidase Consumption Market Share by Application (2014-2019)

      8 Glucosylceramidase Major Manufacturers Analysis

      • 8.1 Amicus Therapeutics, Inc.
        • 8.1.1 Amicus Therapeutics, Inc. Glucosylceramidase Production Sites and Area Served
        • 8.1.2 Amicus Therapeutics, Inc. Product Introduction, Application and Specification
        • 8.1.3 Amicus Therapeutics, Inc. Glucosylceramidase Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Bioorganic Research and Services S.A.
        • 8.2.1 Bioorganic Research and Services S.A. Glucosylceramidase Production Sites and Area Served
        • 8.2.2 Bioorganic Research and Services S.A. Product Introduction, Application and Specification
        • 8.2.3 Bioorganic Research and Services S.A. Glucosylceramidase Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 greenovation Biotech GmbH
        • 8.3.1 greenovation Biotech GmbH Glucosylceramidase Production Sites and Area Served
        • 8.3.2 greenovation Biotech GmbH Product Introduction, Application and Specification
        • 8.3.3 greenovation Biotech GmbH Glucosylceramidase Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 JCR Pharmaceuticals Co., Ltd.
        • 8.4.1 JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Production Sites and Area Served
        • 8.4.2 JCR Pharmaceuticals Co., Ltd. Product Introduction, Application and Specification
        • 8.4.3 JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Pharming Group N.V.
        • 8.5.1 Pharming Group N.V. Glucosylceramidase Production Sites and Area Served
        • 8.5.2 Pharming Group N.V. Product Introduction, Application and Specification
        • 8.5.3 Pharming Group N.V. Glucosylceramidase Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Protalix BioTherapeutics, Inc.
        • 8.6.1 Protalix BioTherapeutics, Inc. Glucosylceramidase Production Sites and Area Served
        • 8.6.2 Protalix BioTherapeutics, Inc. Product Introduction, Application and Specification
        • 8.6.3 Protalix BioTherapeutics, Inc. Glucosylceramidase Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Shire Plc
        • 8.7.1 Shire Plc Glucosylceramidase Production Sites and Area Served
        • 8.7.2 Shire Plc Product Introduction, Application and Specification
        • 8.7.3 Shire Plc Glucosylceramidase Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 The International Biotechnology Center (IBC) Generium
        • 8.8.1 The International Biotechnology Center (IBC) Generium Glucosylceramidase Production Sites and Area Served
        • 8.8.2 The International Biotechnology Center (IBC) Generium Product Introduction, Application and Specification
        • 8.8.3 The International Biotechnology Center (IBC) Generium Glucosylceramidase Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served

      9 Development Trend of Analysis of Glucosylceramidase Market

      • 9.1 Global Glucosylceramidase Market Trend Analysis
        • 9.1.1 Global Glucosylceramidase Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Glucosylceramidase Regional Market Trend
        • 9.2.1 North America Glucosylceramidase Forecast 2019-2025
        • 9.2.2 Europe Glucosylceramidase Forecast 2019-2025
        • 9.2.3 China Glucosylceramidase Forecast 2019-2025
        • 9.2.4 Japan Glucosylceramidase Forecast 2019-2025
        • 9.2.5 Southeast Asia Glucosylceramidase Forecast 2019-2025
        • 9.2.6 India Glucosylceramidase Forecast 2019-2025
      • 9.3 Glucosylceramidase Market Trend (Product Type)
      • 9.4 Glucosylceramidase Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Glucosylceramidase Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Glucosylceramidase. Industry analysis & Market Report on Glucosylceramidase is a syndicated market report, published as Global Glucosylceramidase Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Glucosylceramidase market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,733.50
        4,100.25
        5,467.00
        3,230.50
        4,845.75
        6,461.00
        563,115.00
        844,672.50
        1,126,230.00
        292,285.00
        438,427.50
        584,570.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report